Clinical Report: Liver Supplements: Big Sales, Limited Evidence

Overview

Revise to specify the types of evidence lacking and the implications for consumers.

Background

Liver health is critical for overall well-being, yet the market for liver supplements is booming despite limited evidence supporting their efficacy. Many consumers seek detoxification solutions, often turning to supplements that promise liver health benefits. Understanding the validity of these claims is essential for healthcare professionals to guide patients effectively.

Data Highlights

Key Findings

• All evaluated liver supplements promoted detoxification claims.
• Estimated annual sales across the 20 supplements exceeded $38.8 million.
• 85% of products claimed to enhance liver function.
• 62% of negative reviews cited lack of perceived efficacy.
• Only milk thistle, zinc, choline, and berberine showed moderate clinical evidence.
• Sales were positively correlated with product age and number of reviews.

Clinical Implications

Healthcare professionals should be cautious when recommending liver supplements, as many lack substantial clinical backing. It is important to educate patients about the potential risks associated with these products, particularly given the prevalence of adverse effects reported in reviews.

Conclusion

Strengthen the conclusion by linking findings to consumer and healthcare provider actions.

References

1. Ahmed Telbany, MD, MPH, The American Journal of Gastroenterology, 2023 -- Liver Supplements: Big Sales, Limited Evidence
2. the new gastroenterologist — Steroids show modest 28-day benefit in severe alcohol-associated hepatitis
3. Drug Safety — Guidelines for Enhancing Medication Safety in Individuals with Liver Cirrhosis
4. The New Gastroenterologist — Are Diet Beverages More Detrimental to Liver Health Compared to Sugary Beverages?
5. The New Gastroenterologist — Do Low-Calorie Beverages Pose Greater Risks to Liver Health Compared to Sugary Drinks?
6. Drug, Herbal, and Dietary Supplement–induced Liver Injury | AASLD
7. Steroids show modest 28-day benefit in severe alcohol-associated hepatitis
8. Guidelines for Enhancing Medication Safety in Individuals with Liver Cirrhosis
9. Are Diet Beverages More Detrimental to Liver Health Compared to Sugary Beverages?
10. Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
11. Turmeric - LiverTox - NCBI Bookshelf